BioCatalyst

WVE — Wave Life Sciences Ltd. catalysts

2 verified catalyst event(s) for Wave Life Sciences Ltd. (ticker WVE). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-06-27 — Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53) · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-27
in 5d
ESTIMATED
 READOUT
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWA
Phase 1/2 · Duchenne Muscular Dystrophy
 WVE Wave Life Sciences Ltd. WVE-N531 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses St
Phase 1/2 · Alpha-1 Antitrypsin Deficiency
 WVE Wave Life Sciences Ltd. WVE-006 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.